86 related articles for article (PubMed ID: 2882013)
1. Renal effects of selective alpha-1 and alpha-2 adrenoceptor agonists in conscious, normotensive rats.
Gellai M; Ruffolo RR
J Pharmacol Exp Ther; 1987 Mar; 240(3):723-8. PubMed ID: 2882013
[TBL] [Abstract][Full Text] [Related]
2. Contribution of renal nerves to the natriuretic and diuretic effect of alpha-2 adrenergic receptor activation.
Kline RL; Mercer PF
J Pharmacol Exp Ther; 1990 Apr; 253(1):266-71. PubMed ID: 1970360
[TBL] [Abstract][Full Text] [Related]
3. Existence of spare alpha 1-adrenoreceptors, but not alpha 2-adrenoreceptors, for respective vasopressor effects of cirazoline and B-HT 933 in the pithed rat.
Ruffolo RR; Yaden EL
J Cardiovasc Pharmacol; 1984; 6(6):1011-9. PubMed ID: 6084756
[TBL] [Abstract][Full Text] [Related]
4. Relationship between alpha adrenoceptor occupancy and response for the alpha-1 adrenoceptor agonist, cirazoline, and the alpha-2 adrenoceptor agonist, B-HT 933, in canine saphenous vein.
Ruffolo RR; Zeid RL
J Pharmacol Exp Ther; 1985 Dec; 235(3):636-43. PubMed ID: 2867204
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular responses to the stimulation of alpha-1 and alpha-2 adrenoceptors in the conscious dog.
Woodman OL; Vatner SF
J Pharmacol Exp Ther; 1986 Apr; 237(1):86-91. PubMed ID: 2870177
[TBL] [Abstract][Full Text] [Related]
6. Dose selective dissociation of water and solute excretion after renal alpha-2 adrenoceptor stimulation.
Blandford DE; Smyth DD
J Pharmacol Exp Ther; 1988 Dec; 247(3):1181-6. PubMed ID: 2849664
[TBL] [Abstract][Full Text] [Related]
7. Renal alpha 2a/d-adrenoceptor subtype function: Wistar as compared to spontaneously hypertensive rats.
Intengan HD; Smyth DD
Br J Pharmacol; 1997 Jul; 121(5):861-6. PubMed ID: 9222541
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of nifedipine, nicorandil and nitroglycerin on the pressor responses elicited by selective alpha-1 and alpha-adrenoceptor agonists in conscious dogs.
Wynsen JC; Gross GJ; Brooks HL; Warltier DC
J Pharmacol Exp Ther; 1987 Jun; 241(3):846-54. PubMed ID: 2885410
[TBL] [Abstract][Full Text] [Related]
9. Opposite rank order of potency for alpha-2 adrenoceptor agonists on water and solute excretion in the rat: two sites and/or receptors?
Smyth DD; Li P; Blandford DE; Penner SB
J Pharmacol Exp Ther; 1992 Jun; 261(3):1080-6. PubMed ID: 1351096
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of vasopressin-stimulated cyclic AMP accumulation by alpha-2 adrenoceptor agonists in isolated papillary collecting ducts.
Edwards RM; Gellai M
J Pharmacol Exp Ther; 1988 Feb; 244(2):526-30. PubMed ID: 2894453
[TBL] [Abstract][Full Text] [Related]
11. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
[TBL] [Abstract][Full Text] [Related]
12. Systemic and regional hemodynamic characterization of alpha-1 and alpha-2 adrenoceptor agonists in pithed rats.
Richer C; Lefevre-Borg F; Lechaire J; Gomeni C; Gomeni R; Giudicelli JF; Cavero I
J Pharmacol Exp Ther; 1987 Mar; 240(3):944-53. PubMed ID: 2882016
[TBL] [Abstract][Full Text] [Related]
13. The effect of medetomidine, an alpha 2-adrenoceptor agonist, on plasma atrial natriuretic peptide levels, haemodynamics and renal excretory function in spontaneously hypertensive and Wistar-Kyoto rats.
Ruskoaho H; Leppäluoto J
Br J Pharmacol; 1989 May; 97(1):125-32. PubMed ID: 2566350
[TBL] [Abstract][Full Text] [Related]
14. Localization of alpha 2-adrenoceptor-mediated increase in renal Na+, K+, and water excretion.
Stanton B; Puglisi E; Gellai M
Am J Physiol; 1987 Jun; 252(6 Pt 2):F1016-21. PubMed ID: 3035941
[TBL] [Abstract][Full Text] [Related]
15. Role of alpha-2 receptors in the regulation of renal function.
Strandhoy JW
J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S28-33. PubMed ID: 2417045
[TBL] [Abstract][Full Text] [Related]
16. Alpha 2-adrenoceptor blocking properties of the alpha 1-selective agonist 2-(2-chloro-5-trifluoromethylphenylimino)imidazolidine (St 587).
Pichler L; Kobinger W
Arzneimittelforschung; 1985; 35(1A):201-5. PubMed ID: 2859026
[TBL] [Abstract][Full Text] [Related]
17. In vivo assessment of rat renal alpha adrenoceptors.
Wolff DW; Gesek FA; Strandhoy JW
J Pharmacol Exp Ther; 1987 May; 241(2):472-6. PubMed ID: 2883300
[TBL] [Abstract][Full Text] [Related]
18. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
[TBL] [Abstract][Full Text] [Related]
19. Role of vasopressin in response to intrarenal infusions of alpha-2 adrenoceptor agonists.
Blandford DE; Smyth DD
J Pharmacol Exp Ther; 1990 Oct; 255(1):264-70. PubMed ID: 1976799
[TBL] [Abstract][Full Text] [Related]
20. Possible relationship between receptor reserve and the differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by calcium channel antagonists in the pithed rat.
Ruffolo RR; Morgan EL; Messick K
J Pharmacol Exp Ther; 1984 Sep; 230(3):587-94. PubMed ID: 6088757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
